- $14.96bn
- $19.84bn
- $8.33bn
Solventum to hive off healthcare software business, raises profit forecast
Solventum Q2 sales, adjusted EPS beat estimates; FY outlook lifted
Solventum Corp expected to post earnings of $1.91 a share - Earnings Preview
Solventum forecasts annual profit at higher end on wound care demand
Brief: Solventum Q1 Adjusted EPS USD 1.48 Vs. IBES Estimate USD 1.35
Peltz's Trian urges Solventum to rightsize costs, divest non-core businesses (updated)
Trian urges Solventum to rightsize costs, divest non-core businesses
U.S. RESEARCH ROUNDUP-Adobe, Chevron, Exxon Mobil
U.S. RESEARCH ROUNDUP-Cars.Com, Dell, Zscaler
Solventum Q4 sales beat estimates
Solventum beats quarterly estimates on strong demand for surgical products
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Solventum to buy Acera Surgical for up to $850 million (updated)
Brief: Solventum Announces Agreement To Acquire Acera Surgical
Brief: Solventum Announces $1 Billion Share Repurchase Program
Solventum to buy Acera Surgical for up to $850 million
U.S. STOCKS ON THE MOVE-Akamai Technologies, Enbridge, KKR
U.S. STOCKS ON THE MOVE-Novo Nordisk, Block, Peloton Interactive